The potent ability of small interfering RNA (siRNA) to specifically and efficiently inhibit the expression of complementary RNA transcripts offers a promising alternative therapeutic approach for various diseases.[1] However, the major challenge facing siRNA-based therapy is the requirement of a safe and efficient delivery system for the siRNA.[2] Although viral vectors are highly efficient, their potential inflammatory, immunogenic, and mutagenic ...
